VEGFA and cancer: A similar approach for anti-angiogenic treatment has been assessed several times in multiple cancer types, but despite holding prognostic significance, none of the VEGF ligands or receptors can be used to determine or predict response to anti-angiogenic treatment, regardless of assessment in biopsy material or in blood samples [147].